Ajouter à une liste

Instrument Inactif

Gouvernance BTG

Actions

GB0001001592

Produits pharmaceutiques

Comité Exécutif: BTG

Dirigeant

Fonctions occupéesDepuis

Emily Marie Woodworth

Emily Marie Woodworth

49 ans

Corporate Secretary

16/08/2024

Composition du Conseil d'Administration: BTG

Administrateur

ComitésDepuis

Emily Marie Woodworth

Emily Marie Woodworth

49 ans

Director/Board Member

16/08/2024

Anciens Dirigeants et Administrateurs: BTG

Insider

Fonctions occupées

DepuisJusqu'au

Vance Brown

Director/Board Member	19/08/2019	16/08/2024
Corporate Secretary	19/08/2019	16/08/2024

Jonathan Monson

Jonathan Monson

Director/Board Member

28/02/2020

16/08/2024

Henk Tissing

Corporate Officer/Principal

01/10/2018

01/04/2021

Chris Sampson

Public Communications Contact

-

01/03/2021

Garry Watts

Chairman

01/01/2012

01/01/2020

Duncan Kennedy

Director/Board Member	01/01/2018	31/12/2019
Director of Finance/CFO	01/01/2018	31/12/2019
Corporate Officer/Principal	14/03/2014	01/01/2018

Julia Anastas

General Counsel

01/02/2018

01/12/2019

Graham Hetherington

Graham Hetherington

Director/Board Member	01/08/2016	20/08/2019
Independent Dir/Board Member	07/06/2017	20/08/2019

Pamela Louise Makin

Pamela Louise Makin

Director/Board Member	19/06/2012	01/08/2019
Chief Executive Officer	19/10/2004	01/08/2019

Jamie Heath

Corporate Officer/Principal

01/01/2018

01/08/2019

Kevin L. Espinoza

Kevin L. Espinoza

Compliance Officer

-

01/08/2019

Paul Mussenden

General Counsel

18/03/2010

01/08/2019

Yvonne Rogers

Human Resources Officer

28/08/2009

01/08/2019

Anthony Higham

Corporate Officer/Principal

01/01/2011

01/08/2019

Paul McCubbin

Corporate Officer/Principal

01/01/2001

01/08/2019

Andy Burrows

Investor Relations Contact

-

01/08/2019

Anne Thorburn

Director/Board Member	23/01/2018	01/08/2019
Independent Dir/Board Member	23/01/2018	01/08/2019

Greg Barrett

Director/Board Member	01/11/2017	01/07/2019
Independent Dir/Board Member	01/11/2017	01/07/2019

Giles Kerr

Director/Board Member	01/10/2007	18/07/2018
Independent Dir/Board Member	19/06/2012	18/07/2018

Rolf Soderstrom

Rolf Soderstrom

Director/Board Member	04/12/2008	01/01/2018
Director of Finance/CFO	04/12/2008	01/01/2018

Jeffrey Klimaski

Jeffrey Klimaski

Compliance Officer	-	01/01/2017
Corporate Officer/Principal	-	-

Chris Freitag

Corporate Officer/Principal

01/07/2014

01/06/2016

Matthew Gantz

Corporate Officer/Principal

01/02/2009

01/06/2016

Susan Foden

Director/Board Member	01/03/2015	-
Independent Dir/Board Member	01/03/2015	-

Melanie Lee

Director/Board Member	30/11/2010	25/09/2014
Independent Dir/Board Member	29/11/2010	25/09/2014
Chief Tech/Sci/R&D Officer	01/11/2014	01/01/2018

Charles Brigden

Charles Brigden

Corporate Officer/Principal

01/05/2014

-

Richard Leslie Martin Wohanka

Richard Leslie Martin Wohanka

Director/Board Member	01/01/2013	-
Independent Dir/Board Member	01/01/2013	-

Peter Chambré

Director/Board Member	26/09/2006	25/09/2012
Independent Dir/Board Member	26/09/2006	25/09/2012

John Brown

Chairman	01/01/2008	01/01/2012
Independent Dir/Board Member	23/06/2011	01/01/2012

Sarah Howell

Corporate Officer/Principal

01/09/2009

01/10/2011

William John Jenkins

William John Jenkins

Director/Board Member

28/08/2009

04/02/2011

Peter William Stratford

Peter William Stratford

Chief Tech/Sci/R&D Officer	01/01/2011	-
Corporate Officer/Principal	-	-

John Sylvester

Corporate Officer/Principal

01/01/2011

-

Ian F. R. Much

Director/Board Member	01/08/2010	-
Independent Dir/Board Member	01/08/2010	-

Colin Blakemore

Colin Blakemore

Director/Board Member

01/10/2007

13/07/2010

Christine Soden

Christine Soden

Chief Operating Officer	01/01/2005	30/06/2009
Director of Finance/CFO	-	-

Jim O'Shea

Director/Board Member	02/04/2009	-
Independent Dir/Board Member	02/04/2009	-

Richard Mason

Corporate Officer/Principal

07/04/2009

-

Guenter R. Janhofer

Guenter R. Janhofer

Chief Tech/Sci/R&D Officer	18/01/2012	-
Corporate Officer/Principal	06/04/2009	18/01/2012

James Christie

Chief Operating Officer

28/08/2009

-

Brian Fender

Chairman

-

03/03/2008

Alison Wood

Director/Board Member

01/01/2004

01/01/2008

Fred G. Weiss

Director/Board Member

01/01/2001

01/01/2007

Malcolm Coster

Director/Board Member

-

01/07/2006

Fiona McLaughlin

Fiona McLaughlin

Chief Tech/Sci/R&D Officer

01/01/2003

01/01/2006

Anthony V. Lando

Anthony V. Lando

Chief Operating Officer

01/11/1990

01/06/2005

Larissa Milne

Private Equity Investor

01/01/2001

01/01/2005

Frank Armstrong

Frank Armstrong

Chief Executive Officer

01/01/2003

01/01/2004

Deborah L. Ikirt

Deborah L. Ikirt

Corporate Officer/Principal

-

-

Francis Facchini

Francis Facchini

Corporate Officer/Principal

-

-

Julian Gilbert

Corporate Officer/Principal

-

-

Shawn D. Bridy

Corporate Officer/Principal

-

-

John Librie

Sales & Marketing

-

-

Nasser Saleh

Chairman

-

-

Matthew Frankel

Matthew Frankel

General Counsel

-

-

Clyde Thomas Nixon

Clyde Thomas Nixon

Corporate Officer/Principal

-

-

Donald Dunlop Forrest

Donald Dunlop Forrest

Corporate Officer/Principal

-

-

Ashley Tapp

Public Communications Contact

-

-

Helena Robinette

Helena Robinette

Corporate Officer/Principal

-

-

John Aston

Corporate Officer/Principal

-

-

Christine Podracky

Christine Podracky

Corporate Officer/Principal

-

-

Allan Jackson

Corporate Officer/Principal

-

-

Rusi Kathoke

Director of Finance/CFO

-

-

Donna Hackett

Corporate Officer/Principal

-

-

Marie Lindner

Corporate Officer/Principal

-

-

Stewart Jeffrey Block

Stewart Jeffrey Block

Director/Board Member

-

-

Roger Charles Harrison

Roger Charles Harrison

Corporate Officer/Principal

-

-

Annette M. Tobia

Annette M. Tobia

Chief Executive Officer

-

-

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	1
Femme	0

Dont comité exécutif

Homme	1
Femme	0

Dont Administrateurs

Homme	1
Femme	0

Profil Société

BTG plc est un prestataire de services de développement de dispositifs médicaux et de soins de santé. Elle propose des thérapies de médecine interventionnelle pour le cancer du foie, l'emphysème et les troubles vasculaires, des produits pharmaceutiques spécialisés pour les soins aigus et des activités de licence. Elle opère à travers trois segments : la médecine d'intervention, les produits pharmaceutiques et les licences. Le segment de la médecine interventionnelle comprend l'oncologie, le vasculaire et la pneumologie. Les produits de ce segment comprennent les Beads, TheraSphere, EkoSonic, Varithena et PneumRx Coils, utilisés dans le traitement des tumeurs du foie, des caillots sanguins, des varices et de l'emphysème avancé. Le segment des produits pharmaceutiques comprend les produits CroFab, DigiFab, Voraxaze et Vistogard utilisés dans le traitement de l'envenimation crotalidique, de la toxicité de la digoxine, de la toxicité du méthotrexate à forte dose et de la toxicité du 5-fluorouracile. Le secteur des licences comprend les produits Zytiga, Two-Part Hip Cup et Lemtrada pour le traitement du cancer avancé de la prostate, des prothèses de hanche et de la sclérose en plaques.

Employés

-

Secteur

Produits pharmaceutiques

Plus d'informations sur la société

Départs de Personnes Clées

Garry Watts

-

Chairman

01/01/2012 01/01/2020

Pamela Louise Makin

-

Pamela Louise Makin

Chief Executive Officer

19/10/2004 01/08/2019

John Brown

-

Chairman

01/01/2008 01/01/2012

Brian Fender

-

Chairman

- 03/03/2008

Frank Armstrong

-

Frank Armstrong

Chief Executive Officer

01/01/2003 01/01/2004

Annette M. Tobia

-

Annette M. Tobia

Chief Executive Officer

Nasser Saleh

-

Chairman

Dès maintenant, trouvez facilement les meilleurs investissements de demain !